Antihypertensives and Antianginals Flashcards
Amlodipine Brand Name
Norvasc
Amlodipine Indication/Dosage
Treatment of HTN: start at 5mg daily as monotherapy. If added to existing therapy, start at 2.5mg. Titrate over 7-14 days
Chronic stable or vasospastic angina: 10mg daily
Amlodipine Max Dose
10mg once daily
Amlodipine Mechanism
Calcium Channel Blocker
Inhibits movement of calcium across specific cell membranes in vascular smooth muscle and cardiac muscle (inhibits influx of calcium through slow calcium channels)
More selective for vascular smooth muscle than cardiac muscle
Specific effects:
1) decrease in PVR
2) dilation of coronary arteries and arterioles
3) inhibition of coronary spasm
Amlodipine metabolism and excretion
metabolized in liver
excreted in urine as inactive metabolites
93% protein bound
Amlodipine drug interactions
may increase plasma levels of simvastatin
Amlodipine CI/precautions
rare increase in risk of angina or MI when starting therapy or increasing dose
caution in HF and hepatic impairment
max dose of simvastatin when used with amlodipine is 20mg daily
Amlodipine Pregnancy Category
C
Amlodipine ADR’s
edema, flushing, headache, fatigue, abdominal pain
Amlodipine patient information
may be taken without regards to meals
if dose missed, take ASAP. if taken within 12 hours of the next dose, skip next dose and return to dosing schedule
don’t take OTC cough and cold meds without checking with pharmacist
do not stop therapy unless directed to do so
Amlodipine + Benazepril Brand name
Lotrel
Amlodipine + Benazepril indication/dosage
Hypertension: one capsule daily
lowest possible dose of amlodipine should be used to avoid peripheral edema
use combination in patients who failed monotherapy or who failed amlodipine without developing edema
Amlodipine + Benazepril dosage forms
All Capsules (as Amlodipine/Benazepril)
2.5/10
5/10, 5/20, 5/40
10/20, 10/40
Amlodipine + Benazepril mechanism
Amlodipine: CCB, inhibits influx of calcium ions across slow channels in vascular smooth muscle and cardiac muscle. decreases PVR, dilates coronary arteries, inhibits coronary spasms
Benazepril: ACE-I, decreases plasma angiotensin II, which leads to decreased aldosterone secretion. decreases peripheral arterial resistance
Amlodipine + Benazepril metabolism and excretion
both metabolized in liver
amlodipine excreted as inactive metabolites in urine
Amlodipine + Benazepril drug interactions
Indomethacin: decreases therapeutic effects of Amlodipine + Benazepril
Capsaicin: increases incidence of coughing
use with caution when given with K-sparing diuretics and K supplements
lithium toxicity may occur
amlodipine may increase plasma levels of simvastatin
Amlodipine + Benazepril CI/precautions
CI: second and third trimesters of pregnancy
Caution: renal or hepatic impairment, collagen vascular disease (agranulocytosis) or aortic stenosis, and patients undergoing surgery or anesthesia
report signs of facial swelling, difficulty breathing, infection
Rare: increase in angina or MI on initiation of therapy
Caution in HF patients
Max dose of simvastatin with amlodipine is 20mg daily
Amlodipine + Benazepril Pregnancy category
D
Amlodipine + Benazepril ADRs
cough, headache, dizziness, edema, ANGIOEDEMA, nausea, flushing, fatigue, abdominal pain
Amlodipine + Benazepril patient education
without regard to meal
do not discontinue without consultation
avoid nonprescription cough, cold, and allergy meds unless consulted
avoid salt substitutes containing potassium
report signs of facial swelling, difficulty breathing, or infection
Amlodipine + Valsartan brand name
Exforge
Amlodipine + Valsartan indication/dosage
treatment of HTN in patients not adequately controlled by monotherapy or as initial therapy in patients likely to need multiple medications: start at 5/160 daily, titrate to max dose of 10/320 daily
Amlodipine + Valsartan mechanism
Amlodipine: CCB: inhibits influx of calcium ions across slow channels in vascular smooth muscle and cardiac muscle. causes decrease in PVR, dilation of coronary arteries, and inhibition of coronary spasm
Valsartan: ARB, blocks vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to AT1 receptor
Amlodipine + Valsartan metabolism and excretion
Amlodipine is metabolized in lever and excreted in urine as inactive metabolites
Valsartan is eliminated as unchanged drug in both feces (83%) and urine (13%)
Amlodipine + Valsartan drug interactions
NSAIDS (inc COX-2 inhibitors) may decrease valsartan effects and increase risk of renal function deterioration
amlodipine may increase adverse effects of simvastatin